It seems like you've shared a detailed excerpt from an article or report about advancements in biotechnology focused on creating nonsentient bodies and organ "sacks" as part of efforts to address the organ shortage and explore longevity technologies. The text covers various approaches, companies, and perspectives within this field. Here are some key points:
-
R3 (Rebo's Company): This company is working on producing animals with a "complete lack of ability to feel, think, or sense the environment" by deleting genes in embryos using CRISPR technology. The goal is to create organ "sacks" that can grow mostly on their own and be used for experimental transplants.
-
Stanford University Professors: They have proposed the idea of manufacturing spare human bodies called "bodyoids," which they see as potentially revolutionary but also ethically complex.
-
Harvard Professor George Church: He advises startups in this field and suggests that while nonsentient bodies might be plausible, they are not very useful or socially acceptable yet. He believes focusing on specific organs rather than entire bodies is a more practical approach.
-
Vitalism Movement: This group advocates for redirecting resources toward achieving unlimited lifespans and
Read the full article at MIT Tech Review
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

![[AINews] The Unreasonable Effectiveness of Closing the Loop](/_next/image?url=https%3A%2F%2Fmedia.nemati.ai%2Fmedia%2Fblog%2Fimages%2Farticles%2F600e22851bc7453b.webp&w=3840&q=75)



